Top

Published in:

01-03-2018 | Review Article

Extent of Thyroidectomy in Differentiated Thyroid Cancers—Review of Evidence

Authors: Samskruthi P. Murthy, Deepak Balasubramanian, Adharsh Anand, Shashikant Vishnubhai Limbachiya, Narayana Subramaniam, Vasantha Nair, Krishnakumar Thankappan, Subramania Iyer

Published in: Indian Journal of Surgical Oncology | Issue 1/2018

Abstract

Differentiated thyroid cancers (DTC) are seen with increasing incidence in clinical practice. These tumours have good prognosis and the extent of surgery can be tailored to the size and pathological characteristics of the lesion. Historically total thyroidectomy was the recommended procedure for tumours >1 cm; however, current recommendations suggest a more conservative approach. This review focuses on the evolution of the extent of surgery in differentiated thyroid cancer.

Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164–2167CrossRefPubMed

Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801–3807CrossRefPubMed

Morris LG, Myssiorek D (2010) Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200(4):454–461CrossRefPubMedPubMedCentral

Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112(6):1139–1146 discussion 1146-7PubMed

Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144(6):980–987CrossRefPubMed

Lee J, Park JH, Lee CR, Chung WY, Park CS (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23(11):1408–1415CrossRefPubMed

Gschwandtner E, Klatte T, Swietek N, Bures C, Kober F, Ott J, Schultheis A, Neuhold N, Hermann M (2016) Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: a retrospective study of 1,391 prospective documented patients. Surgery 159(2):503–511CrossRefPubMed

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schulumberger M, Schuff KG, Sherman SI, Sosa JA, Sterward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines for adult patients and differentiated thyroid cancer. Thyroid 26(1):1–133CrossRefPubMedPubMedCentral

Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56(3):171–196CrossRef

10.

Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428CrossRefPubMed

11.

Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA et al (2002) Papillary thyroid carcinoma man- aged at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885CrossRefPubMed

12.

Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214CrossRefPubMed

13.

Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246(3):375–381CrossRefPubMedPubMedCentral

14.

Macedo FI, Mittal VK (2015) Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: a meta-analysis. SurgOncol 24(2):117–122

15.

Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A (2001) Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 11(9):877–881CrossRefPubMed

16.

Pitt SC, Sippel RS, Chen H (2009) Contralateral papillarythyroid cancer: does size matter? Am J Surg 197(3):342–347CrossRefPubMedPubMedCentral

17.

Grigsby PW, Reddy RM, Moley JF, Hall BL (2006) Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 140(6):1043–1047CrossRefPubMed

18.

Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh Q (2016) Frequency of high-risk characteristics requiring Total thyroidectomy for 1-4 cm well-differentiated thyroid. Cancer Thyroid 26(6):820–824CrossRefPubMed

19.

Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J (1976) Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184(5):541–553CrossRefPubMedPubMedCentral

20.

Hay ID, Grant CS, Taylor WF, McConahey WM (1987) Surgery. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102(6):1088–1095PubMed

21.

Shah JP, Loree TR, Dharker D, Strong EW (1993) Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 166(4):331–335CrossRefPubMed

22.

Mendelsohn AH, Elashoff DA, Abemayor E, St John MA (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 136(11):1055–1061CrossRefPubMed

23.

Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260(4):601–605CrossRefPubMedPubMedCentral

24.

Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP (2012) Thyroid lobectomy for treatment of well differentiated intra thyroid malignancy. Surgery 151(4):571–579CrossRefPubMed

25.

Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38(1):68–79CrossRefPubMed

26.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schulumberger M, Schuff KG, Sherman SI, Sosa JA, Sterward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyriod Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines for adult patients and differentiated thyroid cancer. Thyroid 26(1):124–148CrossRef

27.

Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229–1242CrossRefPubMed

28.

Lamartina L, Durante C, Filetti S, Cooper DS (2015) 2015 low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature. J Clin Endocrinol Metab 100:1748–1761CrossRefPubMed

29.

Meltzer C, Klau M, Gurushanthaiah D, Tsai J, Meng D, Radler L, Sundang A (2016) Surgeon volume in thyroid surgery: surgical efficiency, outcomes, and utilization. Laryngoscope 126(11):2630–2639CrossRefPubMed

30.

Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA (2017) Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes? Ann Surg 265(2):402–407CrossRefPubMed

31.

Bhattacharyya N, Fried MP (2002) Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 128(4):389–392CrossRefPubMed

32.

Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, Lausen I (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbeck’s Arch Surg 393(5):667–673CrossRef

33.

Seo GH, Chai YJ, Choi HJ, Lee KE (2016) Incidence of permanent hypocalcaemia after Total thyroidectomy with or without central neck dissection for thyroid carcinoma: a Nationwide claim study. Clin Endocrinol 85(3):483–487CrossRef

34.

Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, Pelizzo MR, Pezzullo L (2004) Complications of thyroid surgery: analysis of a multicentric study on 14,934 patientsoperated on in Italy over 5 years. World J Surg 28(3):271–276CrossRefPubMed

35.

Grover G, Sadler GP, Mihai R (2013) Morbidity after thyroid surgery: patient perspective. Laryngoscope 123(9):2319–2323CrossRefPubMed

36.

Jeannon JP, Orabi AA, Bruch GA, Abdalsalam HA, Simo R (2009) Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review. Int J Clin Pract 63(4):624–629CrossRefPubMed

37.

Shrime MG, Goldstein DP, Seaberg RM, Sawka AM, Rotstein L, Freeman JL, Gullane PJ. Cost-effective management of low-risk papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2007;133(12):1245–1253.

38.

Hirsch D, Levy S, Tsvetov G, Shimon I, Benbassat C (2014) Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma. Oncol Lett 7(3):849–853CrossRefPubMed

39.

Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R, American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association (ATA) - design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22(3):237–244CrossRefPubMed

40.

Udelsman R, Lakatos E, Ladenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20(1):88–93CrossRefPubMed

41.

EsnaolaNF CSB, Sherman SI, Lee JE, Evans DB (2001) Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130(6):921–930CrossRef

42.

Li YJ, Wang YZ, Yi ZB, Chen LL, Zhou XD (2015) Comparison of completion thyroidectomy and primary Total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat 38(10):528–531CrossRefPubMed

43.

Kiernan CM, Parikh AA, Parks LL, Solórzano CC (2015) Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes? J Am Coll Surg 220(4):617–625CrossRefPubMed

44.

Bal C, Singhal T, Kumar R, Verma R, Chandra P, Kumar A, Pant G (2006) Long-term outcome of radioiodine lobar ablation in patients with differentiated thyroid cancer. J Nucl Med 47(suppl 1):324P

45.

Santra A, Bal S, Mahargan S, Bal C (2011) Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer. Nucl Med Commun 32(1):52–58CrossRefPubMed

Title: Extent of Thyroidectomy in Differentiated Thyroid Cancers—Review of Evidence
Authors: Samskruthi P. Murthy
Deepak Balasubramanian
Adharsh Anand
Shashikant Vishnubhai Limbachiya
Narayana Subramaniam
Vasantha Nair
Krishnakumar Thankappan
Subramania Iyer
Publication date: 01-03-2018
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 1/2018
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-017-0661-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Extent of Thyroidectomy in Differentiated Thyroid Cancers—Review of Evidence

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Merkel Cell Carcinoma

Small-Sized Thyroid Cancers—a Single Institutional Experience in India

Staging for Head and Neck Cancer: Purpose, Process and Progress

Papillary Adenocarcinoma in a Gastric Duplication Cyst

Philosophy on Neck Dissection in Thyroid Cancer—Current Controversies and Consensus

Overt Skeletal Metastases in a Patient of Occult (Microscopic) Follicular Thyroid Carcinoma: a Rare Case